Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 po...
Background: Cervical cancer is the fourth common cancer in women worldwide. The Papanicolau test is ...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
Abstract OBJECTIVE: Cervical cancer screening by human papillomavirus (HPV) testing requires the...
OBJECTIVES: To report human papillomavirus (HPV) testing patterns and rates of oncogenic HPV-positiv...
Objectives: To report human papillomavirus (HPV) testing patterns and rates of oncogenic HPV‐positiv...
INTRODUCTION:Screening of young women is often discouraged because of the high risk of unnecessary d...
BACKGROUND: Using primary human papillomavirus (HPV) testing for cervical screening increases detect...
In spite of the success of cervical cytology as a cancer-screening tool, it has important limitation...
Primary HPV screening for cervical cancer by HPV mRNA testing (Aptima)was implemented in January 201...
A fall in the positive predictive value (PPV) of cytological predictions of high-grade squamous intr...
BACKGROUND: Human papillomavirus (HPV) testing is more sensitive than cytology for detecting high-gr...
Background: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catc...
<div><p>Background</p><p>Using primary human papillomavirus (HPV) testing for cervical screening inc...
Background: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catc...
Background—HPV testing is more sensitive than cytology; some cervical cancer prevention programs wil...
Background: Cervical cancer is the fourth common cancer in women worldwide. The Papanicolau test is ...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
Abstract OBJECTIVE: Cervical cancer screening by human papillomavirus (HPV) testing requires the...
OBJECTIVES: To report human papillomavirus (HPV) testing patterns and rates of oncogenic HPV-positiv...
Objectives: To report human papillomavirus (HPV) testing patterns and rates of oncogenic HPV‐positiv...
INTRODUCTION:Screening of young women is often discouraged because of the high risk of unnecessary d...
BACKGROUND: Using primary human papillomavirus (HPV) testing for cervical screening increases detect...
In spite of the success of cervical cytology as a cancer-screening tool, it has important limitation...
Primary HPV screening for cervical cancer by HPV mRNA testing (Aptima)was implemented in January 201...
A fall in the positive predictive value (PPV) of cytological predictions of high-grade squamous intr...
BACKGROUND: Human papillomavirus (HPV) testing is more sensitive than cytology for detecting high-gr...
Background: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catc...
<div><p>Background</p><p>Using primary human papillomavirus (HPV) testing for cervical screening inc...
Background: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catc...
Background—HPV testing is more sensitive than cytology; some cervical cancer prevention programs wil...
Background: Cervical cancer is the fourth common cancer in women worldwide. The Papanicolau test is ...
AimMany cervical cancers occurs among women over 65 and prevalence of HPV genotypes in this age coho...
Abstract OBJECTIVE: Cervical cancer screening by human papillomavirus (HPV) testing requires the...